首页> 外文OA文献 >Diagnostic Findings and ERCP Treatment in Patients with Obstructive Jaundice During Two Years at H. Adam Malik Hospital, Medan
【2h】

Diagnostic Findings and ERCP Treatment in Patients with Obstructive Jaundice During Two Years at H. Adam Malik Hospital, Medan

机译:棉兰H.Adam Malik医院两年来梗阻性黄疸患者的诊断结果和ERCP治疗

摘要

Background: The methods of ERCP have been used for diagnostic and therapeutic purposes to pass bile fluid and extract stones from the bile duct in patients with obstructive extrahepatic jaundice. Method: A retrospective study was performed on patients with obstructive extrahepatic jaundice patients who underwent ERCP during a two-years time period from January 1999 to December 2000. ERCP was performed with a premedication of 10 mg midazolam, followed by a chollangiography contrast containing 1 mg/dl of Garamicin and 25 mg of Pethidine if sphincterotomy was performed. Results: From 126 patients with obstructive extrahepatic jaundice treated with ERCP, the male to female ratio was 1.86:1. The majority of the (group) of patients were between 51-60 years of age (33.3 % ). The youngest patient (group) was 24 years and the oldest 97 years. The diagnostic study found the following cases: normal 3 cases (2.8%), bile duct stone 46 cases (43.4%), carcinoma of ampula vater 20 cases (18.9%), CBD tumor 7 cases (6.6%), carcinoma of head of pancreas 2 cases (1.9%), diverticle 4 cases (3.8%), duodenal tumor 1 case (0.9%), carcinoma of ampula vater and bile duct stone 1 case (0.9%), SOD 5 cases (4.7%), CBD stricture 1 case (0.9%) and failure 16 cases (15.1%). The patients receivied the following treatment: sphyncterotomy 36 cases (51.4%), stent application 11 cases ( 15.7%), sphincterotomy with stent 18 cases (25.7%) and basket method 5 cases (7.1%).
机译:背景:ERCP方法已被用于诊断和治疗目的,用于阻塞性肝外黄疸患者的胆汁液通过并从胆管中提取结石。方法:对1999年1月至2000年12月的两年内接受ERCP的梗阻性肝外黄疸患者进行回顾性研究。ERCP的处方药为咪达唑仑10 mg,胆道造影对比为1 mg如果进行括约肌切开术,则加拉米丁/ dl和25 mg的哌啶。结果:126例接受ERCP治疗的梗阻性肝外黄疸患者的男女比例为1.86:1。大多数患者(组)年龄在51-60岁之间(33.3%)。最年轻的患者(组)是24岁,最大的是97岁。诊断研究发现以下病例:正常3例(2.8%),胆管结石46例(43.4%),壶腹癌20例(18.9%),CBD肿瘤7例(6.6%),头颅癌胰腺2例(1.9%),憩室4例(3.8%),十二指肠肿瘤1例(0.9%),骨和胆管结石癌1例(0.9%),SOD 5例(4.7%),CBD狭窄1例(0.9%),失败16例(15.1%)。患者接受了以下治疗:括约肌切开术36例(51.4%),支架置入11例(15.7%),括约肌切开支架联合18例(25.7%)和篮法5例(7.1%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号